cinoxate | 83834-60-0

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: cinoxate
• 英文别名: 2-ethoxyethyl para-methoxycinnamate；ethylhexyl methoxycinnamate；2-ethoxy ethyl-p-methoxy cinnamate；2-ethoxy ethyl-p-methoxycinnamate；2-ethoxyethyl p-methoxy cinnamate；2-ethoxyethyl p-methoxycinnamate；2-ethoxyethyl (E)-3-(4-methoxyphenyl)prop-2-enoate
• CAS: 83834-60-0
• 化学式: C₁₄H₁₈O₄
• 分子量: 250.295
• InChiKey: CMDKPGRTAQVGFQ-RMKNXTFCSA-N

物化性质

• 沸点：
  374.6±22.0 °C(Predicted)
• 密度：
  1.086±0.06 g/cm3(Predicted)
• 物理描述：
  2-ethoxyethyl-p-methoxycinnamate is a viscous clear to pale yellow liquid. Insoluble in water. (NTP, 1992)
• 颜色/状态：
  Viscous liquid, may have slight yellow tinge
• 气味：
  Practically odorless
• 熔点：
  -25.0 °C
• 闪点：
  greater than 212 °F (NTP, 1992)
• 溶解度：
  Insoluble (NTP, 1992)
• 蒸汽压力：
  1.6X10-5 mm Hg at 25 °C (est)
• 折光率：
  Index of refraction: 1.567 at 20 °C

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  18
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

ADMET

毒理性

• 相互作用

减少紫外线（UV）光通过表皮的渗透，通过吸收特定波长范围内的UV辐射。吸收的UV辐射的量和波长受到防晒剂分子结构的影响。/防晒剂，外用/

Diminish the penetration of ultraviolet (UV) light through the epidermis by absorbing UV radiation within a specific wavelength range. The amount and wavelength of UV radiation absorbed are affected by the molecular structure of the sunscreen agent. /Sunscreen agents, topical/

来源:Hazardous Substances Data Bank (HSDB)

毒理性

• 解毒与急救

/SRP:/ 立即急救：确保已经进行了充分的中毒物清除。如果患者停止呼吸，开始人工呼吸，最好使用需求阀复苏器、袋阀面罩装置或口袋面罩，按训练操作。如有必要，执行心肺复苏。立即用缓慢流动的水冲洗受污染的眼睛。不要催吐。如果发生呕吐，让患者前倾或置于左侧（如果可能的话，头部向下），以保持呼吸道畅通，防止吸入。保持患者安静，维持正常体温。寻求医疗帮助。 /毒物A和B/

/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/

来源:Hazardous Substances Data Bank (HSDB)

毒理性

• 解毒与急救

/SRP:/ 基本治疗：建立专利气道（如有需要，使用口咽或鼻咽气道）。如有必要，进行吸痰。观察呼吸不足的迹象，如有需要，辅助通气。通过非循环呼吸面罩以10至15升/分钟的速度给予氧气。监测肺水肿，如有必要，进行治疗……。监测休克，如有必要，进行治疗……。预防癫痫发作，如有必要，进行治疗……。对于眼睛污染，立即用水冲洗眼睛。在运输过程中，用0.9%的生理盐水（NS）持续冲洗每只眼睛……。不要使用催吐剂。对于摄入，如果患者能吞咽、有强烈的干呕反射且不流口水，则用温水冲洗口腔，并给予5毫升/千克，最多200毫升的水进行稀释……。在去污后，用干燥的无菌敷料覆盖皮肤烧伤……。/毒药A和B/

/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poisons A and B/

来源:Hazardous Substances Data Bank (HSDB)

毒理性

• 解毒与急救

/SRP:/ 高级治疗：对于无意识、严重肺水肿或严重呼吸困难的病人，考虑进行口咽或鼻咽气管插管以控制气道。使用气囊面罩装置的正压通气技术可能有益。考虑使用药物治疗肺水肿……。对于严重的支气管痉挛，考虑给予β激动剂，如沙丁胺醇……。监测心率和必要时治疗心律失常……。开始静脉输注D5W /SRP: "保持开放"，最小流量/。如果出现低血容量的迹象，使用0.9%的生理盐水（NS）或乳酸林格氏液。对于伴有低血容量迹象的低血压，谨慎给予液体。注意液体过载的迹象……。使用地西泮或劳拉西泮治疗癫痫……。使用丙美卡因氢氯化物协助眼部冲洗……。 /Poisons A and B/

/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag valve mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Consider administering a beta agonist such as albuterol for severe bronchospasm ... . Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start IV administration of D5W /SRP: "To keep open", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poisons A and B/

来源:Hazardous Substances Data Bank (HSDB)

毒理性

• 人类毒性摘录

/其他毒性信息/ 防晒霜的局部使用可以减少人类晒伤的风险。当主要在无意中暴露在阳光下时，防晒霜可能预防皮肤鳞状细胞癌。关于防晒霜的局部使用对基底细胞癌和皮肤黑色素瘤的预防作用，无法得出结论。使用防晒霜可能会延长有意晒太阳的时间，比如日光浴。这样的延长可能会增加皮肤黑色素瘤的风险。 /防晒霜/

/OTHER TOXICITY INFORMATION/ Topical use of sunscreens reduces the risk for sunburn in humans. Sunscreens probably prevent squamous-cell carcinoma of the skin when used mainly during unintentional sun exposure. No conclusion can be drawn about the cancer-preventive activity of topical use of sunscreens against basal-cell carcinoma and cutaneous melanoma. Use of sunscreens can extend the duration of intentional sun exposure, such as sunbathing. Such an extension may increase the risk for cutaneous melanoma. /Sunscreens/

来源:Hazardous Substances Data Bank (HSDB)

吸收、分配和排泄

防晒产品中使用的溶剂影响药物与皮肤的稳定性和结合；一般来说，醇类溶剂允许防晒霜最快速和最深层次地穿透表皮。看来防晒剂被完整的表皮不同程度地吸收。/防晒霜/

Solvents used in sunscreen products affect the stability and binding of the drug to the skin; in general, alcoholic solvents allow for the most rapid and deepest epidermal penetration of sunscreens. It appears that sunscreen agents are absorbed by the intact epidermis to varying degrees. /Sunscreens/

来源:Hazardous Substances Data Bank (HSDB)

反应信息

• 作为反应物：
  描述：

  西诺沙酯 、 cinoxate 生成 环己基(E)-3-(4-甲氧基苯基)丙-2-烯酸酯
  参考文献：
  名称：

  Sunscreen composition containing polyisobutylene and its use for the

  摘要：

  本发明涉及一种防晒霜组合物，其包含至少一种油溶性吸收紫外线的剂和至少一种在常温下为液态、粘度平均分子量在8,000至65,000之间的聚异丁烯，并在至少一种脂肪相的化妆品可接受介质中。这样的防晒霜组合物，涂抹在皮肤上，具有改善的保护指数。

  公开号：

  US04925653A1
• 作为产物：
  描述：

  (E)-4-[2-(phenylsulfonyl)vinyl]anisole 在 tetrabutylammonium tetrafluoroborate 、 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 8.0h， 生成 cinoxate
  参考文献：
  名称：

  α,β-不饱和砜的立体选择性电化学羧化

  摘要：

  二氧化碳(CO 2 )作为一种极具吸引力的C1合成子，已广泛用于有机合成中生产羧酸。在这项研究中，在无过渡金属的条件下开发了α,β-不饱和砜的立体选择性电化学羧化反应。所有肉桂酸及其衍生物均以E构型选择性地获得。此外，芳基丙炔酸酯也可以由炔基砜生产。

  DOI：

  10.1016/j.cclet.2022.107956

文献信息

• [EN] ENCAPSULATES<br/>[FR] PRODUITS ENCAPSULÉS
  申请人：PROCTER & GAMBLE

  公开号：WO2013022949A1

  公开（公告）日：2013-02-14

  The present application relates to encapsulates, compositions, products comprising such encapsulates, and processes for making and using such encapsulates. Such encapsulates comprise a core comprising a perfume and a shell that encapsulates said core, such encapsulates may optionally comprise a parametric balancing agent, such shell comprising one or more azobenzene moieties.

  本申请涉及封装体、组合物、包含这种封装体的产品，以及制备和使用这种封装体的方法。这种封装体包括一个包含香水的核心和封装该核心的壳，这种封装体可以选择性地包含一个参数平衡剂，该壳包括一个或多个偶氮苯基团。
• PHOTOPROTECTIVE COMPOSITIONS COMPRISING PHOTOSENSITIVE 1,3,5-TRIAZINE COMPOUNDS, DIBENZOYLMETHANE COMPOUNDS AND SILICEOUS S-TRIAZINES SUBSTITUTED WITH TWO AMINOBENZOATE OR AMINOBENZAMIDE GROUPS
  申请人：L'OREAL

  公开号：US20170135933A1

  公开（公告）日：2017-05-18

  UV-photoprotective, topically applicable cosmetic/dermatological compositions contain: (a) at least one dibenzoylmethane compound, (b) at least one 1,3,5-triazine compound that is photosensitive in the presence of a dibenzoylmethane compound, and (c) at least one siliceous s-triazine compound substituted with two aminobenzoate or aminobenzamide groups, or a tautomeric form thereof, the 1,3,5-triazine compounds being improvedly photostable in such compositions.

  UV-光保护，可局部应用的化妆品/皮肤科组合物包含： (a) 至少一种二苯甲酮化合物， (b) 至少一种1,3,5-三嗪化合物，在二苯甲酮化合物存在时对光敏感，以及 (c) 至少一种含有两个氨基苯甲酸酯或氨基苯酰胺基团的硅质s-三嗪化合物，或其互变异构体，这些1,3,5-三嗪化合物在这种组合物中具有改进的光稳定性。
• Use of Mineral/Organic Composite Material in the Form of an Ultraviolet Radiation Protective Agent
  申请人：Daniele Stephane

  公开号：US20090104135A1

  公开（公告）日：2009-04-23

  The invention relates to the use of composite material which comprises nanoparticles of a least one metal derivative and at least one organic sunscreen agent which is chemically bound with said particles in a covalent manner in the form of an ultraviolet radiation protective agent containing the inventive composite material. Cosmetic ultraviolet radiation protective compositions comprises said mixture are also disclosed.

  该发明涉及使用复合材料，该复合材料包括至少一种金属衍生物的纳米颗粒和至少一种有机防晒剂，该有机防晒剂以共价方式与所述颗粒化学结合，形成一种含有所述创新复合材料的紫外辐射防护剂。还公开了包含所述混合物的化妆品紫外辐射防护组合物。
• [EN] HEMI-AMINAL ETHERS AND THIOETHERS OF N-ALKENYL CYCLIC COMPOUNDS<br/>[FR] ÉTHERS ET THIOÉTHERS HÉMIAMINAUX DE COMPOSÉS CYCLIQUES N-ALCÉNYLIQUES
  申请人：ISP INVESTMENTS INC

  公开号：WO2014116560A1

  公开（公告）日：2014-07-31

  Described herein are hemi-aminal ethers and thioethers of N-alkenyl cyclic compounds that may be produced through a reaction comprising: (A) at least one first reactant represented by a structure (I), wherein X is a functionalized or unfunctionalized C1-C5 alkylene group optionally having one or more heteroatoms, and each R1, R2, and R3 is independently selected from the group consisting of hydrogen and functionalized and unfunctionalized alkyl groups optionally having one or more heteroatoms, and (B) at least one second reactant having at least one hydroxyl moiety or thiol moiety. The hemi-aminal ethers and thioethers of N-alkenyl cyclic compounds may comprise a polymerizable moiety, in which case they may be left as-is or used to create homopolymers or non-homopolymers, or they may not comprise a polymerizable moiety. A wide variety of formulations may be created using the hemi-aminal ethers and thioethers of N-alkenyl cyclic compounds, including personal care, oilfield, and construction formulations.

  本文描述了可以通过反应制备的N-烯基环状化合物的半胺醚和硫醚，所述反应包括：（A）至少一个由结构（I）表示的第一反应物，其中X是一个官能化或非官能化的C1-C5烷基烯烃基团，可选地具有一个或多个杂原子，每个R1、R2和R3分别独立地选自氢和官能化和非官能化的烷基基团，可选地具有一个或多个杂原子；和（B）至少一个具有至少一个羟基基团或硫醇基团的第二反应物。N-烯基环状化合物的半胺醚和硫醚可能包括一个可聚合的基团，此时它们可以保持原样或用于制备同聚物或非同聚物，或者它们可能不包括可聚合的基团。可以使用N-烯基环状化合物的半胺醚和硫醚制备各种配方，包括个人护理、油田和建筑配方。
• SUNSCREEN COMPOSITIONS
  申请人：L'OREAL

  公开号：US20040126336A1

  公开（公告）日：2004-07-01

  The present invention relates to improved sunscreen compositions, more preferably to improved sunscreen compositions containing at least one sunscreening agent (sunscreen) and a silicone-polyamide copolymer.

  本发明涉及改进的防晒霜组合物，更具体地涉及至少含有一种防晒剂（防晒剂）和一种硅-聚酰胺共聚物的改进防晒霜组合物。